Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation
Clinical trial NCT04338958 · COMPLETED
Trial details
- NCT number
- NCT04338958
- Sponsor
- University of Jena
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-22
- Primary completion
- 2021-07-15
- Enrollment
- 193
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.